Carbamazepine: Difference between revisions
| Line 52: | Line 52: | ||
|} | |} | ||
Note Plasma concentration for optimum response 4-12 mg/litre (20-50 micromol/litre) | |||
==Side Effects== | |||
Common side effects include: | |||
*Drowsiness, dizziness and headaches | |||
*Gastrointestinal disturbances, such as nausea and vomiting | |||
*The loss of full control of bodily movements (motor coordination impairment) | |||
*Increased risks of hyponatremia and SIADH | |||
*Blood disorders (such as decreased white blood cell or platelet counts) | |||
Serious side effects may include: | |||
*Skin rashes, exfoliative dermatitis, epidermal necrolysis, Stevens-Johnson syndrome, and SLE | |||
*Decreased bone marrow function | |||
*Suicidal thoughts | |||
*Abnormal heart rhythms | |||
*Blurry or double vision, nystagmus | |||
*Male infertility | |||
*Osteoporosis | |||
*Gynecomastia | |||
*Galactorrhea | |||
Revision as of 21:51, 7 October 2020
Carbamazepine(中文: 卡馬西平) is an anticonvulsant medication used primarily in the treatment of epilepsy and neuropathic pain. Carbamazepine appears to work as well as phenytoin and valproate for focal and generalized seizures. It is not effective for absence or myoclonic seizures. It is used in schizophrenia and as a second-line agent in the management of bipolar disorder unresponsive to lithium.
Drug Names
| Generic Name 藥名 | HA Code 藥物代碼 | Classification藥物分類 |
|---|---|---|
| Carbamazepine Suspension 100mg/5ml | CARB49 | P1S1S3 |
Mechanism of Action
Anticonvulsant medication. It is a sodium channel blocker. It binds to sodium channels and suppresses repetitive neuronal firing.
Dosage
| Epilepsy | Oral: initially 100 – 200 mg 1-2 times daily, increased slowly by increments of up 200 mg daily every week to an usual maintenance dose of 0.8 – 1.2 g daily in divided doses; up to 2 g daily may occasionally be necessary.
By rectum: for short-term use (Max. 7 days) when oral therapy temporarily not possible; 125-mg suppository approximately equivalent to 100-mg tablet, but final adjustment should always depend on clinical response. Max. 1 g daily in 4 divided doses. Elderly: reduce initial dose. Child: the usual daily dose may be given according to age as follows:
The maximum recommended daily dose, according to age, is as follows:
|
|---|---|
| Trigeminal neuralgia | Oral: initially 100 mg 1-2 times daily, increased gradually according to response; usual dose 200 mg 3-4 times daily, up to 1.6 g daily in some patients |
| Bipolar disorder | Oral: initially 400 mg daily in divided doses increasleed until symptoms controlled; usual range 400-600 mg daily; max. 1.6 g daily |
| Treatment of alcohol withdrawal | Oral: initially 800 mg daily in divided doses, reduced gradually over 5 days to 200 mg daily; usual treatment duration 7-10 days. |
| Diabetic neuropathy | Oral: initially 100 mg 1-2 times daily, increased gradually according to response; usual dose 200 mg 3-4 times daily, up to 1.6 g daily in some patients |
Note Plasma concentration for optimum response 4-12 mg/litre (20-50 micromol/litre)
Side Effects
Common side effects include:
- Drowsiness, dizziness and headaches
- Gastrointestinal disturbances, such as nausea and vomiting
- The loss of full control of bodily movements (motor coordination impairment)
- Increased risks of hyponatremia and SIADH
- Blood disorders (such as decreased white blood cell or platelet counts)
Serious side effects may include:
- Skin rashes, exfoliative dermatitis, epidermal necrolysis, Stevens-Johnson syndrome, and SLE
- Decreased bone marrow function
- Suicidal thoughts
- Abnormal heart rhythms
- Blurry or double vision, nystagmus
- Male infertility
- Osteoporosis
- Gynecomastia
- Galactorrhea
